RBC Bioscience Corporation (6848.TWO)
TWD 18.0
(-9.09%)
TWD 18.0
(-9.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.54 Million TWD | 15.81% |
| 2022 | 32.12 Million TWD | -48.45% |
| 2021 | 62.3 Million TWD | -67.69% |
| 2020 | 192.86 Million TWD | 888.14% |
| 2019 | 24.85 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 14.77 Million TWD | -2.37% |
| 2024 Q1 | 15.13 Million TWD | 81.04% |
| 2023 Q1 | 7.57 Million TWD | 217.35% |
| 2023 Q4 | 8.35 Million TWD | 0.0% |
| 2023 Q2 | 7.57 Million TWD | 0.0% |
| 2023 FY | - TWD | 15.81% |
| 2023 Q3 | 8.35 Million TWD | 10.4% |
| 2022 Q3 | 2.38 Million TWD | 0.0% |
| 2022 FY | - TWD | -48.45% |
| 2022 Q4 | 2.38 Million TWD | 0.0% |
| 2021 FY | - TWD | -67.69% |
| 2020 FY | - TWD | 888.14% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 179.031% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 90.715% |
| Level Biotechnology Inc. | 98.7 Million TWD | 62.973% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 181.689% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 150.679% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 244.838% |
| GlycoNex Incorporation | -126.82 Million TWD | 128.816% |
| VBI | -6.97 Million TWD | 624.197% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 125.434% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -67.57% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 306.177% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 135.272% |
| Visgeneer Inc. | 973 Thousand TWD | -3656.115% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 110.765% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 96.097% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 63.393% |
| Neith Corporation | -33.61 Million TWD | 208.738% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 103.688% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 2204.03% |
| Enimmune corporation | -228.96 Million TWD | 115.962% |
| TaiRx, Inc. | -208.64 Million TWD | 117.516% |
| CHO Pharma, Inc. | -277.73 Million TWD | 113.159% |
| EirGenix Inc. | -664.4 Million TWD | 105.501% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 50.548% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 47.143% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 103.411% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 132.312% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -4.906% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 158.624% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 238.962% |
| BiOptic Inc. | 65.03 Million TWD | 43.807% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 105.355% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 210.728% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 166.552% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 91.57% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 145.643% |
| NaviFUS Corp. | -55.79 Million TWD | 165.502% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 320.189% |
| Sinew Pharma Inc. | -163.63 Million TWD | 122.335% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 159.426% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 81.005% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 116.123% |
| AP Biosciences Inc | -325.51 Million TWD | 111.228% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 103.499% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 201.956% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -25.462% |
| Intech Biopharm Corporation | -219.58 Million TWD | 116.644% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 105.421% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 181.304% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 122.72% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 94.425% |
| TCI GENE Inc. | 25.98 Million TWD | -40.668% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 133.033% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 112.878% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 125.037% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -163.877% |
| PharmaEngine, Inc. | 347.3 Million TWD | 89.477% |
| Savior Lifetec Corporation | 219.6 Million TWD | 83.358% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 78.78% |
| OBI Pharma, Inc. | -855.08 Million TWD | 104.274% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 139.483% |
| Acepodia, Inc. | -764.51 Million TWD | 104.78% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 107.943% |